Premium
Switching to aflibercept in patients with neovascular age‐related macular degeneration not responding to bevacizumab: a pilot study
Author(s) -
Asten Freekje,
Klevering B. Jeroen,
Hoyng Carel B.
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.13146
Subject(s) - aflibercept , bevacizumab , ranibizumab , medicine , macular degeneration , ophthalmology , vascular endothelial growth factor , oncology , vegf receptors , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom